- By Priyanka Munshi
- Thu, 09 Jan 2025 05:44 PM (IST)
- Source:JND
Human Metapneumovirus (HMPV) is a respiratory virus that has been present in various countries for many years. It is important to understand that HMPV is entirely distinct from COVID-19 in both its characteristics and impact. Unlike COVID-19, which emerged as a novel virus and caused a global pandemic, HMPV is a known pathogen that has been studied extensively over the years. In a conversation with Jagran English, Dr. Vikas Mittal, a Pulmonologist at the CK Birla Hospital in Delhi, discussed whether HMPV is another COVID-19-like scare in China and what is known so far.
On January 7, the World Health Organization (WHO) issued a report clarifying the current situation concerning respiratory illnesses in China. According to the report, there is no abnormal increase in HMPV cases in China. The virus primarily circulates during the winter months, similar to other respiratory pathogens. The rise in respiratory illnesses in China has been attributed to influenza, Mycoplasma, and respiratory syncytial virus (RSV), all of which are common during colder seasons.
The WHO report further emphasized that there is no unusual spike in hospitalizations or cases related to HMPV in China. The current situation does not indicate any signs of another COVID-19-like global health crisis. Unlike COVID-19, which had a profound and sudden impact on healthcare systems worldwide, HMPV generally causes mild respiratory illnesses in most individuals. However, high-risk groups, including young children, older adults, and immunocompromised individuals, may experience more severe symptoms. Even in such cases, the virus is manageable with standard medical care.
Dr. Vikas Mittal highlighted the importance of staying informed and avoiding unnecessary panic. The respiratory illnesses currently reported in China align with seasonal trends, and health authorities are actively monitoring the situation to address any unusual patterns promptly. He also recommended preventive measures, such as maintaining good hygiene, wearing masks in crowded spaces, and isolating when symptomatic, to minimize the spread of respiratory infections, including HMPV. Individuals experiencing severe or persistent respiratory symptoms are advised to consult healthcare professionals.
In conclusion, Dr. Vikas Mittal stated that while HMPV is a known respiratory virus, there is no evidence to suggest it is causing an unusual outbreak or public health crisis in China or elsewhere. The current rise in respiratory illnesses is largely due to seasonal factors, and proactive health measures remain the best defense against such infections. HMPV is not another COVID-19 scare, and the situation remains under control.
